2019
DOI: 10.1016/j.jff.2018.11.007
|View full text |Cite
|
Sign up to set email alerts
|

Naringin abrogates HIV-1 protease inhibitors-induced atherogenic dyslipidemia and oxidative stress in vivo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
4
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 45 publications
1
4
0
Order By: Relevance
“…This increase in redox imbalance was ameliorated by Nar treatment in a dose-dependent manner, possibly by its direct ability to scavenge free radicals [37], or through the transcriptional up-regulation of antioxidant genes [38]. These results are consistent with reports of other investigators [31,39,40]. Several studies have reported that the antioxidant and anti-inflammatory effects of Nar are retained up to 400 mg/kg exposure [41][42][43].…”
Section: Discussionsupporting
confidence: 86%
“…This increase in redox imbalance was ameliorated by Nar treatment in a dose-dependent manner, possibly by its direct ability to scavenge free radicals [37], or through the transcriptional up-regulation of antioxidant genes [38]. These results are consistent with reports of other investigators [31,39,40]. Several studies have reported that the antioxidant and anti-inflammatory effects of Nar are retained up to 400 mg/kg exposure [41][42][43].…”
Section: Discussionsupporting
confidence: 86%
“…Human immunodeficiency virus (HIV) protease inhibitors are used in therapy for HIV infection, which causes sustained suppression of viral replication (Nzuza & Owira, 2019). Dyslipidemia and its complications, such as atherosclerosis and endothelial dysfunction, are the side effects of HIV protease inhibitors treatment (Nzuza & Owira, 2019).…”
Section: Targeting Er Stress By Bbr Under Pathological Conditionsmentioning
confidence: 99%
“…Human immunodeficiency virus (HIV) protease inhibitors are used in therapy for HIV infection, which causes sustained suppression of viral replication (Nzuza & Owira, 2019). Dyslipidemia and its complications, such as atherosclerosis and endothelial dysfunction, are the side effects of HIV protease inhibitors treatment (Nzuza & Owira, 2019). Multiple mechanisms are involved in complications associated with the HIV protease inhibitors, including apoptosis inflammation and ER stress (Gruevska et al, 2021; Nzuza & Owira, 2019).…”
Section: Targeting Er Stress By Bbr Under Pathological Conditionsmentioning
confidence: 99%
See 2 more Smart Citations